Michael Boland, MD, AGS 22: Findings of Clinical Trials and Future Emerging Technologies

We were delighted to speak with Prof. Michael Boland (Massachusetts Eye and Ear, Boston, MA, USA) about the findings of clinical trials investigating methods of assessing disease progression and emerging technologies in the future.

The presentation entitled ‘Measuring Disease Progression in Clinical Trials’ was presented at the 2022 American Glaucoma Society Annual Meeting, March 03-06, 2022.

Disclosures: Michael Boland is a consultant for Carl Zeiss Meditec, Topcon and Allergan

Questions:

1. What clinical trials are investigating methods of assessing disease progression? (00:21)
2. What have been the findings of studies to date? (01:17)
3. What emerging technologies do you expect to be useful in the future? (02:24)

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.

Filmed in coverage of the virtual AGS 2022.